• No results found

HUMAN EMBRYONIC STEM CELL LINES: THE ETHICS OF DERIVATION

N/A
N/A
Protected

Academic year: 2021

Share "HUMAN EMBRYONIC STEM CELL LINES: THE ETHICS OF DERIVATION"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

(1)

HUMAN EMBRYONIC STEM CELL LINES:

THE ETHICS OF DERIVATION

Fran~oise Baylis, PhD

Departments of Bioethics and Philosophy, Dalhousie University, Halifax NS

Abstract: In Canada it is permissible to proceed with stem cell research using human embryos created by in vitro fertilization (IVF) provided: these were originally created for infertility treatment; they are no longer required for such treatment; and there is an appropriate consent for their research use.As such, IVF human embryos in excess of clinical need are a valu-able resource for embryonic stem cell researchers. A point often overlooked, however, is that these excess IVF human embryos are also a scarce resource. Their scarcity suggests the need to develop sound policies and procedures, in a time-ly and coordinated fashion, to ensure that the few human embryos available for embryonic stem cell research are not used in less important research endeavours or used when other biological materials are appropriate. Injudicious use of the few human embryos available for research use may risk the following consequences: no ongoing research in Canada to derive human embryonic stem cell lines; a reliance on the importation of stem cell lines from other countries for any research on the use of embryonic stem cells; and pressure from Canadian researchers to remove the prohibition on the purposeful creation of human embryos for research use.

Resume : Au Canada, il est permis de poursuivre la recherche sur les cellules embryonnaires creees par fecondation in vitro

(FIV), pourvu que: elles aient ete creees pour un traitement contre I'infecondite; elles ne soient plus utiles pour ce traite-ment; et qu'on ait obtenu un consentement eclaire permettant leur utilisation pour la recherche. En tant que tels, les embryons humains excedentaires produits par FIV sont une ressource importante pour les chercheurs qui font de la recherche sur les cellules embryonnaires. On oublie souvent, cependant, que ces embryons humains excedentaires crees par FIV sont aussi une ressource rare. Cette rarete temoigne de la necessite de mettre en place des principes et methodes adequats, en temps opportun et de maniere coordonnee, pour s'assurer que les quelques embryons humains pouvant etre utilises pour la recherche sur les cellules embryonnaires ne font pas I'objet de recherches d'une importance moindre ou qu'elles ne sont pas utilisees quand d'autres materiels biologiques pourraient repondre aux besoins. Si les quelques KeyWords

Human embryo research, stem cell research, scientific merit, legislation, regulation

Franc;oise Baylis is an Associate Theme Leader for the Stem Cell Network (A Network of Centres of Excellence) and was a member of the CIHR Ad Hoc Working Group on Stem Cell Research. The views expressed herein are her own.

JOGe

embryons humains pouvant etre utilises pour la recherche ne sont pas utilises de fac;on judicieuse, nous risquons de voir les consequences suivantes : il n'y aura plus de recherche au Canada visant

a

deriver des lignees cellulaires des cellules embryonnaires; nous devrons dependre de I'importation de lignees cellulaires embryonnaires d'autres pays pour pouvoir poursuivre la recherche sur I'utilisation des cellules embryon-naires; des pressions seront faites sur les chercheurs cana-diens pour supprimer I'interdiction de creer des embryons humains pour la recherche.

J

Obstet Gynecol Can 2002;24(2): I 59-63, INTRODUCTION

The promise of human stem cell research is considerable, including the development of stem cell transplants to treat fail-ing organs and to replace diseased or damaged tissues. In the media there are constant references to future stem cell treat-ments for Alzheimer's disease, Parkinson's disease, heart disease, chronic liver failure, diabetes, and so on, Some researchers argue that to secure these therapeutic benefits it is necessary to do research involving human embryos, while others insist that the relevant research can be done using stem cells derived from less morally controversial sources. I In time we will know which of

these arguments is accurate.

Human embryonic stem cell research, though controver-sial, is being actively pursued in a number of jurisdictions. 2 Human embryonic stem (ES) cell lines can be derived from human embryos created by in vitro fertilization (IVF) or creat-ed by somatic cell nuclear transfer (SCNT) involving the enu-cleation of a woman's oocyte. Indeed, research involving both IVF and SCNT embryos is expressly permitted in some juris-dictions, including, most notably, the United Kingdom.3,4 In contrast, in Canada the prevailing view is that research to derive human ES cell lines should be limited to the use of cryo-preserved IVF embryos remaining after infertility treatment. This is the view expressed in the TN-Council Policy Statement:

Ethical Conduct for Research Involving Humans (August 1998),5

the Canadian Institutes of Health Research (CIHR) Discussion Paper Human Stem Cell Research: Opportunities for Health and

Ethical Perspectives (March 2001),6 the Government of Canada's

(2)

draft legislation on Assisted Human Reproduction (May 2001),7 and the Report of the House of Commons Standing Commit-tee on Health (December 2001).8

Common to these documents is a prohibition on the pur-poseful creation of human embryos for research use. Only embryos created by IVF for reproductive purposes but no longer required for these purposes are deemed legitimate research ma-terial. The limited number of such embryos raises important questions that must be addressed in a timely and coordinated fashion to ensure that the few human embryos potentially available for stem cell research are not used in less important research endeavours, or used when other biological materials are appropriate, such as polyspermic human embryos from IVF fertilizations.

In Canada, at the present time, there are no regulations or fed-erallegislation governing research involving human embryos, but only research guidelines, as outlined in the Tri-Council

Policy Statement. As concerns embryonic stem cell research these

guidelines are very thin, and for this reason CIHR is develop-ing additional guidelines. Because guidelines are oflimited force, and because research involving human embryos is morally con-troversial, the federal government is considering introducing legislation. Such legislation would be the ultimate authority with respect to what embryo research would be permissible in Canada. Hints of what might be legislated can be found in the draft legislation prepared by Health Canada and recently reviewed by the Standing Committee on Health. Below, sum-mary details are provided regarding the policy context in which human embryonic stem cell research may proceed in Canada.

TRI-COUNCIL POLICY STATEMENT

The Tri-Council Policy Statement applies to all research

involv-ing humans, which includes human tissues, biological fluids, embryos, and fetuses. These guidelines govern research direct-ly funded by the federal granting councils (including CIHR) and research in institutions that receive funding from the grant-ing councils. These guidelines stipulate that:

It is not ethically acceptable to create human embryos

specif-ically for research purposes. However, in those cases where human embryos are created for reproductive purposes and subsequently are no longer required for such purposes, research involving human embryos may be considered to be

ethically acceptable ... 5

Such research is ethically acceptable provided free and informed consent of the gamete donors has been given; there are no commercial transactions involved, including exchange for service; the research does not involve any genetic alteration

of the embryos; there is no transfer to the uterus of any

embryos manipulated in ways not directly relevant to their ongoing normal development; and the research does not exceed 14 days. Further, these guidelines expressly prohibit the cloning of human beings by any means, including SCNT.

CIHR AD HOC WORKING GROUP ON STEM CELL RESEARCH

The CIHR Ad Hoc Working Group on Stem Cell Research, in its initial Discussion Paper, proposed that research on existing human ES cell lines should be permitted, as should research to derive and study human ES cell lines using IVF embryos no longer required for reproductive purposes. The cloning of humans for either reproductive or therapeutic purposes should be prohibited. More details regarding the scope of research eli-gible for CIHR funding and the requirements for a morally valid consent to ES cell research are expected in the final docu-ment to be released in early 2002.

DRAFT FEDERAL LEGISLATION ON

ASSISTED HUMAN REPRODUCTION

The Government of Canada's draft legislation on Assisted

Human Reproduction states: "No person shall knowingly create

an in vitro embryo solely for research purposes."7 Further, the

draft legislation proposes that all research involving human embryos be a controlled activity, only permissible under licence issued in accordance with regulations:

No person shall, except under the authority of a licence issued under subsection 12(1), make use of any in vitro embryo or part of one for the purpose of research or the prevention, diag-nosis or treatment of a disease, injury or disability.

The draft legislation also stipulates that: "No person shall knowingly create or participate in the creation of a human clone ... " A human clone is defined as "an embryo that as a result of the manipulation of human reproductive material contains the same nuclear deoxyribonucleic acid sequence as is found in the cell of a living or deceased human being, foetus or embryo. "7

PARLIAMENTARY STANDING COMMITTEE ON HEALTH

The Parliamentary Standing Committee on Health has endorsed the elements of the draft legislation that pertain to research involving human embryos. As regards the use of embryos for stem cell research, the Standing Committee fur-ther recommends that no licence be issued "unless the applicant clearly demonstrates that no other category of biological ma-terial could be used for the purposes of the proposed research."8 This proposed restriction, were it to be included in the revised

Assisted Human Reproduction legislation, would narrow the

(3)

IVF HUMAN EMBRYOS DONATED FOR RESEARCH USE

The consensus in Canada is that human ES cell research should be limited to IVF human embryos originally created fo~ repro-ductive purposes but now in excess of clinical need. The most probable sources of such embryos are existing IVF human embryos in cryopreservation storage that have been (or will be) donated for research use, and future IVF human embryos that will be created for reproductive purposes and frozen for pos-sible later use.

In Canada, the total number of human embryos in stor-age is unknown, as there is no common repository for this information. The total is believed to be quite limited. Current statistics from the Fertility Centre at the Ottawa Hospital-Civic Site will serve to make the point about scarcity. Currently the Ottawa clinic does approximately 10% of the IVF cycles in Canada and the clinic's experience with embryo freezing dates back to 1991. Since 1991, 3,252 human embryos have been frozen and currently there are 815 embryos in storage. From 1991 through 2001, 159 frozen embryos have been donated for research purposes. Of these embryos, 109 have been used for research and there are now 50 embryos in stor-age that are available for research use.9

If we extrapolate from this data, we can perhaps estimate that in Canada there are currently 500 frozen "excess" IVF human embryos available for research. This total could be a serious overestimation, however, as not all IVF clinics have a ten-year history of freezing human embryos. A program with a shorter history of embryo freezing would likely have a small-er numbsmall-er of embryos in storage for research or othsmall-er use. Fur-ther, some consent forms will not have described (and requested consent for) the possible future research use of frozen IVF human embryos. Other consent forms will have identi-fied research as an option for the disposal of unwanted frozen embryos, but will have done so in a way that would preclude the use of these embryos for stem cell research. This would be true, for example, with any forms modelled on Schedule 2 of the Human Fertilisation and Embryology Act of the UK, where human embryo research was originally limited to diagnostic methods and fertility treatments.3

Conversely, the estimated total of 500 frozen IVF human embryos available for research use could be a serious under-estimation. One reason for this possibility is that not all IVF clinics have the same consent renewal process. In some clinics, the current wishes of some of those who have embryos in stor-age is unknown; a subset of these individuals might want to donate their frozen embryos for research use. Another factor that seriously compromises the ability to make any kind of accurate estimate of the total number of frozen IVF human embryos available for research in Canada is the difference in policies and practices among the IVF clinics regarding the research use of frozen embryos. While many clinics in which JOGC

cryopreserved human embryos are available for research will use some of these embryos to test culture conditions, train embryologists, and improve IVF and adjunct technologies such as pre-implantation genetic diagnosis, other clinics will some-times use polyspermic embryos in these situations and thus may have larger numbers of cryopreserved human embryos still available for research. The scope of research undertaken in the clinic clearly affects the number of embryos in storage and potentially available for research use.

In future, might the number of frozen embryos increase? To be sure, increased awareness on the part of clinicians and researchers as to the potential benefits of embryonic stem cell research could result in important changes to current institu-tional policies, practices, and consent forms, in an effort to increase the number ofIVF embryos available for research gen-erally, and stem cell research particularly. As well, increased media attention on the potential benefits of stem cell trans-plantation (i.e., regenerative medicine), may encourage per-sons accessing infertility treatment to donate unwanted embryos for research use. These are reasonable assumptions. It is equally reasonable to suppose, however, that these sorts of changes will not result in a major change in the number of frozen embryos available on a cyclical basis for research use for at least the following reasons.

First, IVF clinics are already creating the maximum num-ber of human embryos necessary for reproductive success. To change this practice in order to increase the number of embryos created (and possibly made available for research) would be tantamount to the purposeful creation of human embryos for research purposes, which is prohibited, and would expose women to unnecessary high doses of drugs and other additional treatment risks, which is unethical. Second, there is a growing trend for IVF clinics to culture developing human embryos to the blastocyst stage. Many of these embryos die in vitro, and so a reduction in the overall num-ber of embryos being frozen is to be expected. Third, if Assist-ed Human Reproduction legislation is introducAssist-ed, it is reasonable to anticipate that some of the smaller IVF clinics may not be able to meet the practice standards established and may close. Some of the larger clinics may be able to increase the number of cycles they do per year, but owing to certain capacity restrictions, it is equally likely that there will be a reduction in the annual number of IVF cycles in Cana-da and a concomitant decrease in the number of embryos cre-ated and frozen for possible subsequent research use. Finally, if ova storage techniques are perfected, there will be less need for, and use of, embryo freezing. For these reasons, an increase in the number of frozen IVF human embryos available for research use is unlikely. In fact, the opposite is more likely once ova storage techniques are perfected.

(4)

A SCARCE RESOURCE

With this background information about the likely sources of "excess" IYF human embryos for research use, consider the fol-lowing additional facts:

1. At anyone point in time there will be a limited number of frozen IYF human embryos available for research use and the vast majority of these will be frozen embryos.

2. Of the frozen embryos available for research use, not all will be available for stem cell research.

3. Of those that are destined for stem cell research, approxi-mately 50% will not survive the freeze-thaw process to go on to divide.

4. Of those that do go on to divide, and from which the inner cell mass can be removed for stem cell research, perhaps as few as 7.5% will generate cell lines (this percentage is from research involving fresh embryos created for stem cell research using donor gametes and is likely to be an overestimation of the success rate using previously frozen embryos).10

5. Finally, not all of these cell lines will meet Thomson and colleagues' essential characteristics of human ES cell lines, which include prolonged undifferentiated proliferation and stable developmental potential to form derivatives of all three embryonic germ layers even after prolonged culture. 11

For illustrative purposes, we can apply this reasoning to the estimated 500 frozen IVF embryos currently available for research in Canada. For the sake of argument, let us assume that 250 (50%) of these embryos will be used for stem cell research. Only 125 (50%) of these embryos would be expect-ed to survive the freeze-thaw process and go on to divide. Of these 125 embryos, approximately 9 (7.5%) would be expect-ed to generate cell lines. Some, but not all, of these cell lines would satisfY the criteria for human ES cell lines and be avail-able for select stem cell research projects. The small number of ES cell lines likely to be created from the estimated total of 500 frozen embryos available for research (which may be an overestimation if there are fewer than 500 frozen embryos avail-able for research and ifless than 50% of this total is availavail-able for stem cell research) brings into sharp focus the need to attend very carefully to the scientific merit of any proposed embryonic stem cell research project.

SCIENTIFIC MERIT AND THE PROBLEM OF WASTAGE Iii' I

7

The requirement of scientific merit can be parsed into the requirements of scientific validity and scientific value:

A study is scientifically valid provided it is designed to yield

reliable information according to accepted principles of research practice ... A second and distinct understanding of the requirement of scientific merit focuses upon "value" rather than (mere) "validity". A study may be well designed

relative to its hypothesis, and therefore be scientifically valid, but nonetheless be of no value, generally because the hypothesis itself is trivial or otherwise uninteresting. 12 In exploring this distinction Freedman concludes that where-as scientific validity is a precondition for ethical research, scien-tific value "needs to be judged within the context of all other elements of the ethics of research, and so should not be put forth as a prior condition for separate consideration." 12 As such, sci-entific value is not an absolute prior threshold condition for research involving embryos, whereas scientific validity is.

In the context of human embryo research, scientific valid-ity, at minimum, requires good research design based on prior laboratory and animal research, competent investigators, and adequate research facilities. Embryological research that is poor-ly designed and poorpoor-ly executed wastes embryos - a scarce and valuable research resource. To avoid such wastage, it is partic-ularly important that any proposed research be sufficiently well designed to achieve its purposes and that it occur within a con-text where there is confidence that the proposed design will be implemented. Secondly, the requirement of competent inves-tigators and adequate facilities highlights the need to avoid other, perhaps inadvertent, types of embryo wastage. If the investigators lack the requisite training and experience in the techniques being used, if the laboratory conditions do not include good culture facilities, facilities for microscopic exam-ination, appropriate incubators, and training in "non touch" techniques, or if the security, record-keeping, and labelling practices are inadequate, it is again reasonable to anticipate wastage of research material.

In addition to the requirement of scientific validity there is the requirement of scientific value. This requirement under-lines the need to avoid embryo wastage in experiments where the hypothesis is unimportant and uninteresting, where the research would generate non-generalizable results, or where there is substantial overlap with proven research results. 13 As well, in recent years the requirement of social value has been added to the requirement of scientific value to underline the importance of pursuing research of potential benefit to indi-viduals and the community-at-large. In sum, ethical embryo research must be valuable, where "value" encompasses both scientific interests as well as social consequences.

Taken together, these requirements - scientific validity and scientific and social value - argue for a coordinated approach to the research use ofIYF human embryos, to effectively ensure that these embryos are used for the very best project(s), by the very best team(s), with the very best facilities. From this view-point, human embryos should not, as a matter of course, be available to the highest bidder, the most senior investigator by reputation, or the most proximate research team.

One conclusion that follows from this is that all human embryo research, whether privately or publicly funded, should

(5)

be subject to national rigorous scientific peer review and research ethics review. This review should be of the highest quality and a model of openness and transparency. By itself, however, national review may not address the problem of scarcity, since there may be many more valid and valuable research projects than could successfully be undertaken with the few IVF human embryos available for research. To address this problem, the traditional review system would need to be substantially modified to allow for a comparative evaluation of projects on the basis of "value."

Comparing the relative value of different research pro-posals is what commonly happens with peer review of grant applications where there are limited research resources (i.e., grant funds) to be distributed. The same needs to happen with the review of embryo research where there are limited research resources (i.e., biological material) to be distributed. This sug-gests a second conclusion: that IVF human embryos should be considered a common resource and that a national elec-tronic registry of human embryos available for research use should be established.

To say the least, proceeding in this way and explicitly choosing to consider frozen IVF human embryos as a com-mon resource (for which sound public policies and scientific research procedures must be developed to ensure their careful and proper use), would be a novel way of doing science. It

would require of people with unwanted IVF human embryos that they donate these to a common pool (as happens in a therapeutic context with the donation of other tissues such as blood). fu well, this approach would require both willingness and ability on the part of members of the scientific commu-nity to harness the efforts of researchers and to orient these to a common national goal. Arguably, Canadians expect no less from the best of their citizens and scientists, whom they pre-sume to be committed to the pursuit of scientifically and eth-ically sound research. Anything less risks both foreclosing research on the derivation of human embryonic stem cells, and limiting research on the use of human embryonic stem cells to research on imported cell lines. In turn, such consequences could be expected to lead researchers to challenge the current prohibition on creating human embryos for research pur-poses: a prohibition that is a core aspect of Canadian policy on human embryo research. Upholding this prohibition requires proactive measures of the type described above to minimize the risk of wasting the few IVF human embryos available for research use.

ACKNCNYLEDGEMENTS '§I

Research support provided by fusociated Medical Services Inc. and The Stem Cell Network.

JOGC

REFERENCES

I. National Institutes of Health, Stem Cells: Scientific Progress and Future Research Directions,June 200 I.

<http://www.nih.gov/news/stemceil/scireport.htm>

2. Baylis F. Human embryonic stem cell research. Canadian Chemical News Jan 2002:30-31.

3. Human Fertilisation and Embryology Act, c. 37, 1990. <http://www.legis-lation.hmso.gov.uklacts/acts I 990/Ukpga_19900037 _en_l.htm> 4. Human Fertilisation and Embryology (Research Purposes) Regulations

200 I, Statutory Instrument 200 I No. 188.

<http://www.legislation.hmso.gov.uklsilsi2001/20010188.htm> 5. The Tri-Council Policy Statement: Ethical Conduct for Research

Involving Humans. 1998.

<http://www.nserc.calprograms/ethics/english/index.htm> 6. Canadian Institutes of Health Research. Human stem cell research:

opportunities for health and ethical perspectives: a discussion paper. <http://www.cihr.calgovernin&-council/ad_hoc_working..groups/stem_ ceILe.pdf>

7. Health Canada. Draft legislation on assisted human reproduction. <http://www.hc-sc.gc.calenglish/reproduction/legislation.pdf>. For a brief summary see, Baylis F. Canadian regulation of assisted reproductive tech-nologies? Hastings Center Report 200 I ;31 (4):8. For a commentary see, Baylis F. Brickbats and bouquets for the draft legislation on assisted human reproduction. Health Law Review 200 I; I O( I ):3-7.

8. Standing Committee on Health. House of Commons Standing Commit-tee of Health Report on Proposal for Legislation on Assisted Human Reproduction. <http://www.parl.gc.ca/lnfoComDoc/37/I/HEAUStud-ies/Reports/healrpO I-e.htm>

9. Personal communication Dr. Marie-Claude Leveille, Fertility Centre, Ottawa Hospital - Civic site.

10. Lanzendorf SE, Boyd CA,Wright DL, Muasher S, Oehninger S, Hodgen GD. Use of human gametes obtained from anonymous donors for the production of human embryonic stem cell lines. Fertil Steril 200 I ;76( I): 132-7.

I I. Thomson JA, Itskovitz-Eldor J, Shapiro, et al. Embryonic stem cell lines derived from human blastocysts.Science 1998;282:1145-7.

12. Freedman B. Scientific value and validity as ethical requirements for research: a proposed explication.IRB 1987;9(6):7-10.

13. Emanuel E, Wendler D, Grady C. What makes clinical esearch ethical? JAm Med Assoc 2000; 283(20):270 I-I I.

References

Related documents

Esse tom paródico está exposto no jogo metanarrativo, no qual narrar e brincar se confundem: “Verdi quis cobri-los [Leonora e Álvaro] de música, sangue e marshmallow, pelas salas

I agree that if the card is lost or stolen, I agree to immediately notify the bank issuing the card and the Ector County ISD Program Administrator verbally and in writing (e-mail is

Next we (1) illustrate why input constraints can help sym- bolic execution find more bugs and improve testing coverage and (2) summarize how DASE extracts these types of con-

Results from the early surveys in the 1990s point to huge overall differences in food habits between these two areas (Puska et al. However, the recent trends and

Using the migration of observed and synthetic DAS seismic records, we recognized intense seismic reflections from 2.8–3.0 km depth, suggesting the possibility of

In general from the previous study the effect of different irrigation method on water use efficiency, yield productivity and nitrogen application (yield and

a) When the course is to be specified in a program structure at an academic level (e.g. postgraduate) different from the program (e.g. undergraduate) for which it was